Volume 5, Issue 6 , 2005
Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression
Pp: 431-432
Author(s): Paul Schoenhagen and Steven E. Nissen
DOI: 10.2174/156800605774962013
Animal Models of Atherosclerosis Progression: Current Concepts
Pp: 433-440
Author(s): A. C. McMahon, L. Kritharides and H. C. Lowe
DOI: 10.2174/156800605774962031
HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol
Pp: 441-453
Author(s): R. Kleemann and T. Kooistra
DOI: 10.2174/156800605774962077
Cholesterol Absorption Blockade with Ezetimibe
Pp: 455-462
Author(s): Peter P. Toth and Michael H. Davidson
DOI: 10.2174/156800605774962086
Inhibitors of Acyl-Coenzyme A: Cholesterol Acyltransferase
Pp: 463-469
Author(s): Akira Miyazaki, Tomoko Kanome and Takuya Watanabe
DOI: 10.2174/156800605774962040
ApoA-I Milano/phospholipid Complexes Emerging Pharmacological Strategies and Medications for the Prevention of Atherosclerotic Plaque Progression
Pp: 471-479
Author(s): Sanjay Kaul and Prediman K. Shah
DOI: 10.2174/156800605774962004
Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?
Pp: 481-488
Author(s): W. A. Van der Steeg, K. El-Harchaoui, J. A. Kuivenhoven and J. J.P. Kastelein
DOI: 10.2174/156800605774961997
A Rationale for Combined Therapy with a Calcium Channel Blocker and a Statin: Evaluation of Basic and Clinical Evidence
Pp: 489-501
Author(s): R. P. Mason
DOI: 10.2174/156800605774962112
Preventing Atherosclerosis with Angiotensin-Converting Enzyme Inhibitors: Emphasis on Diabetic Atherosclerosis
Pp: 503-512
Author(s): T. J. Allen and K. A. Jandeleit-Dahm
DOI: 10.2174/156800605774962068
Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis
Pp: 513-525
Author(s): I. Gouni-Berthold and W. Krone
DOI: 10.2174/156800605774962022
Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis
Pp: 527-532
Author(s): A. Zalewski, C. Macphee and J. J. Nelson
DOI: 10.2174/156800605774962103
Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases
Pp: 533-540
Author(s): Dennis Bruemmer and Ronald E. Law
DOI: 10.2174/156800605774961988
Matrix Metalloproteinases: A Potential Therapeutic Target in Atherosclerosis
Pp: 541-548
Author(s): Mustapha Rouis
DOI: 10.2174/156800605774961979
Endocannabinoid Receptor Antagonists and Other Emerging Pharmacological Strategies for Weight Reduction
Pp: 549-556
Author(s): Kishore M. Gadde
DOI: 10.2174/156800605774962095
Non-invasive Atherosclerosis Imaging: Use to Assess Response to Novel or Combination Lipid Therapies
Pp: 557-564
Author(s): Todd C. Villines and Allen J. Taylor
DOI: 10.2174/156800605774962059